| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/14/2010 | EP2205623A1 Protective skin care tetrapeptides |
| 07/14/2010 | EP1079859B1 Bifunctional molecules and therapies based thereon |
| 07/14/2010 | CN101775066A Method for synthesizing neotame |
| 07/13/2010 | US7754885 tubulysin derivatives used as antitumor agents |
| 07/13/2010 | US7754684 Macromolecular platinum chelates |
| 07/13/2010 | US7754466 Method for producing dipeptides |
| 07/13/2010 | CA2427837C Radioactive member for use in brachytherapy and method of making |
| 07/08/2010 | WO2010077783A1 Hepatitis c virus inhibitors |
| 07/08/2010 | WO2010076654A2 CYSTEINE-FREE EFFICIENT TECHNETIUM (Tc) OR RHENIUM (Re) CHELATING PEPTIDE TAGS AND THEIR USE |
| 07/08/2010 | WO2010075983A1 Process for the production of bivalirudin |
| 07/08/2010 | US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 07/08/2010 | US20100173352 Method for preparing cells for engraftment |
| 07/08/2010 | US20100172967 Compound modified with glycerol derivative |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172864 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 07/08/2010 | CA2745946A1 Cysteine-free efficient technetium (tc) or rhenium (re) chelating peptide tags and their use |
| 07/08/2010 | CA2744627A1 Process for the production of bivalirudin |
| 07/07/2010 | EP2204383A1 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 07/07/2010 | EP2204377A1 Cysteine-free technetium (tc) or rhenium (re) chelating peptide tags and their use |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | CN101772507A proteasome inhibitors |
| 07/07/2010 | CN101768209A Hypotensive peptide with high in-vivo activity and preparation and purification method thereof |
| 07/07/2010 | CN101768208A Novel 18F-labelled polypeptide, preparation method and application thereof in tumor imaging |
| 07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 07/06/2010 | US7750116 for treating refractory or drug resistant cancer, cell proliferative disorder and tumor cells |
| 07/06/2010 | US7750115 Epithelial cell growth promoter |
| 07/06/2010 | US7749969 N- or C- terminally modified small peptides |
| 07/06/2010 | US7749967 immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100; peptide being reactive with T cells or inducing an immune response; anticarcinogenic agents |
| 07/06/2010 | US7749966 Compositioncomprising somatomedin polypeptide for use in generating immunoglobulins which bind, inactivate or suppress activity from insulin-like growth factor 1 receptor; antitumor agents; immunotherapy |
| 07/06/2010 | US7749961 Macrocyclic peptides active against the hepatitis C virus |
| 07/06/2010 | US7749958 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents |
| 07/06/2010 | US7749954 Use of calcitonin in osteoarthritis |
| 07/06/2010 | US7749742 Method for producing tripeptides and/or peptides longer than tripeptides |
| 07/01/2010 | WO2010075127A1 Antiviral compounds |
| 07/01/2010 | WO2010074591A1 Creatine amides, a method for the production thereof and an agent exhibiting a neuroprotective action |
| 07/01/2010 | WO2010074542A2 NANOSTRUCTURES HAVING STABILIZED MULTIPLE α-HELICAL STRUCTURES, SELF-ASSEMBLING MACROCYCLIC COMPOUNDS FOR FORMING THE NANOSTRUCTURES, AND METHODS OF PREPARING THE COMPOUND |
| 07/01/2010 | WO2010073870A1 Liver disease marker, method and apparatus for measuring same, and test method for pharmaceutical preparation |
| 07/01/2010 | WO2010072927A1 Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing same |
| 07/01/2010 | WO2010072926A1 Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same |
| 07/01/2010 | WO2010072314A1 Dipeptoid prodrugs and the use thereof |
| 07/01/2010 | US20100168384 Anti-viral compounds |
| 07/01/2010 | US20100168381 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 07/01/2010 | US20100168039 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 07/01/2010 | US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors |
| 07/01/2010 | US20100168019 Peptide conjugated anti-cancer prodrugs |
| 07/01/2010 | US20100167995 Peptoid compounds |
| 07/01/2010 | US20100166706 Hcv ns-3 serine protease inhibitors |
| 07/01/2010 | CA2746834A1 Antiviral compounds |
| 07/01/2010 | CA2746711A1 Dipeptoid prodrugs and the use thereof |
| 06/30/2010 | CN101759767A Method for synthesizing glycylglycine |
| 06/29/2010 | US7745577 cyclic peptide having amino acid sequences amidated or hydroxylated at the carboxy terminus and conjugated to a detectible agent and/or a cytotoxic agent, used for detecting tumors and preventing transformation of normal cells into tumor cells |
| 06/29/2010 | US7745576 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 06/29/2010 | US7745444 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 06/29/2010 | US7745405 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence; fusion proteins for tissue-targeted therapy |
| 06/29/2010 | US7745388 Peptide for use in the treatment of cell damage caused by ischemia |
| 06/29/2010 | US7745172 Via L-aspartic acid- alpha,beta-diester and L-phenylalanine using enzyme that has ability to selectively link L-phenylalanine to alpha -ester site of L-aspartic acid- alpha,beta-diester through peptide bond/nucleophilic attack; easy, high yield and inexpensively without going through a complex synthesis |
| 06/29/2010 | US7744853 Radiolabeled annexins |
| 06/29/2010 | CA2636421C A method of platelet and whole blood storage |
| 06/29/2010 | CA2442881C New process for the industrial synthesis of the tetraesters of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis ofbivalent salts of ranelic acid and their hydrates |
| 06/29/2010 | CA2405521C Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 06/24/2010 | WO2010071833A1 Proteinase k inhibitors, methods and compositions therefor |
| 06/24/2010 | WO2010071132A1 Peptide for inhibiting skin aging |
| 06/24/2010 | WO2010046298A3 Improved peptide availability |
| 06/24/2010 | US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 06/24/2010 | US20100160241 Novel compound having gpr54 agonistic activity |
| 06/24/2010 | US20100160213 Antimicrobial and anticancer lipopeptides |
| 06/24/2010 | US20100158933 Ige ch3 peptide vaccine |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/23/2010 | EP2199300A2 Peptidic compounds |
| 06/23/2010 | EP2198875A1 A method for reducing the likelihood of preterm labour in a subject in need thereof |
| 06/23/2010 | EP2198723A1 Inflammation inhibiting compounds |
| 06/23/2010 | EP2197897A1 Amino acid pairing-based self assembling peptides and methods |
| 06/23/2010 | CN101754974A Macrocyclic compounds as antiviral agents |
| 06/23/2010 | CN101747411A Aminoacyl tryptophyl tryptophan tripeptide benzyl ester as well as preparation method and application thereof |
| 06/23/2010 | CN101747410A Aminoacyl tyrosyl tryptophan tripeptide with easing pain activity and preparation method and application thereof |
| 06/23/2010 | CN101747226A N-oxalic acid acyl amino acid derivatives and N-oxalic acid acyl dipeptide derivatives as well as applications thereof in preparation of consciousness-promoted drugs |
| 06/22/2010 | US7741436 Injecting the tripeptide, Lys-Asp-Ile, derived from the neurite outgrowth-promoting domain of laminin-1, into the epidural space of the spine to regenerate the tissue |
| 06/22/2010 | US7741433 Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof |
| 06/22/2010 | US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof |
| 06/22/2010 | US7741288 serine/threonine phosphatases (PP1); immobilization, screening |
| 06/22/2010 | US7741286 kringle peptides; peptidase stabilized |
| 06/22/2010 | US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 06/22/2010 | CA2536926C Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 06/22/2010 | CA2441398C Lipid lowering biphenylcarboxamides |
| 06/22/2010 | CA2420996C Substituted heterocyclic compounds for treating multidrug resistance |
| 06/22/2010 | CA2374346C Inhibitors of memapsin 2 and use thereof |
| 06/17/2010 | WO2010068714A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors |
| 06/17/2010 | US20100152420 Peptide networks |
| 06/17/2010 | US20100152103 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
| 06/17/2010 | US20100152099 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 06/17/2010 | US20100151486 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
| 06/17/2010 | DE102008062567A1 Dipeptoid-Prodrugs und ihre Verwendung Dipeptoid prodrugs and their use |
| 06/17/2010 | CA2746258A1 Deuterated compounds as hepatitis c virus (hcv) inhibitors |
| 06/16/2010 | EP2196210A1 A method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/16/2010 | EP2196202A1 Inflammation-inhibiting compounds Lys-Pro-Thr and Lys-Pro |
| 06/16/2010 | EP2195329A2 Methods and intermediates for chemical synthesis of polypeptides and proteins |
| 06/16/2010 | CN1802384B Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 06/16/2010 | CN1518558B Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 06/16/2010 | CN1406249B Enhancing the circulating half-life of antibody-based fusion proteins |